In silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist as a Possible Treatment for Obesity and Type 2 Diabetes. Tikrit Journal of Pharmaceutical Sciences, [S. l.], v. 20, n. 1, p. 51–66, 2026. DOI: 10.25130/tjphs.2026.20.1.6.51.66. Disponível em: https://tjphs.tu.edu.iq/index.php/j/article/view/673. Acesso em: 8 aug. 2026.